scholarly journals Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation

2010 ◽  
Vol 45 (11) ◽  
pp. 1645-1652 ◽  
Author(s):  
A Carvalho ◽  
C Cunha ◽  
M Di Ianni ◽  
L Pitzurra ◽  
T Aloisi ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Genetic Variants ◽  
Prognostic Significance

scholarly journals Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients

Cancer Cell ◽  
2021 ◽  
Vol 39 (12) ◽  
pp. 1654
Author(s):  
Patrick Harrington ◽  
Katie J. Doores ◽  
Chandan Saha ◽  
Jamie Saunders ◽  
Fiona Child ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Response ◽  
T Cell Response

Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation

2018 ◽  
Vol 32 (4) ◽  
pp. e13220 ◽  
Author(s):  
Xiaofei Yang ◽  
Shuo Yang ◽  
Aining Sun ◽  
Huiying Qiu ◽  
Xiaowen Tang ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Cyclosporine A ◽  
Allogeneic Stem Cell Transplantation

What is the future of immunotherapy in multiple myeloma?

Blood ◽  
2020 ◽  
Vol 136 (22) ◽  
pp. 2491-2497
Author(s):  
Leo Rasche ◽  
Michael Hudecek ◽  
Hermann Einsele
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibodies ◽  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Therapies ◽  
The Future

Abstract The treatment of multiple myeloma (MM) is currently being redefined by humoral and cellular immunotherapies. For decades, there was limited belief in immune-based anti-MM therapy as a result of the moderate graft-versus-myeloma effect of allogeneic stem cell transplantation. Today, monoclonal antibodies comprise the new backbone of anti-MM therapy, and T-cell therapies targeting BCMA are emerging as the most potent single agents for MM treatment. Herein, we present our assessment of and vision for MM immunotherapy in the short and midterm.

scholarly journals T cell regeneration in pediatric allogeneic stem cell transplantation

2007 ◽  
Vol 39 (3) ◽  
pp. 149-156 ◽  
Author(s):  
H Olkinuora ◽  
K Talvensaari ◽  
T Kaartinen ◽  
S Siitonen ◽  
U Saarinen-Pihkala ◽  
...  
Keyword(s):  
Stem Cell ◽  
T Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Allogeneic Stem Cell Transplantation ◽  
Cell Regeneration
Sign in / Sign up

Export Citation Format

Share Document